help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paulmyer-Lacroix, O.
Right arrow Articles by Grino, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paulmyer-Lacroix, O.
Right arrow Articles by Grino, M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Nutrition
*Obesity
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 6 2701-2705
Copyright © 2002 by The Endocrine Society

The Impact of the Human Genome on Endocrinology: Original Articles

Expression of the mRNA Coding for 11ß-Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue from Obese Patients: An in Situ Hybridization Study

Odile Paulmyer-Lacroix, Sandrine Boullu, Charles Oliver, Marie-Christine Alessi and Michel Grino

Laboratoire de Neuroendocrinologie Expérimentale (O.P.-L., S.B., C.O., M.G.), Institut National de la Santé et de la Recherche Médicale U501, UFR de Médecine secteur Nord, Institut Jean Roche, and Laboratoire d’Hématologie (M.-C.A.), Institut National de la Santé et de la Recherche Médicale EPI 99–36, UFR de Médecine secteur Timone, Université de la Méditerranée, Marseille, France

Address all correspondence and requests for reprints to: Michel Grino, M.D., Ph.D., Laboratoire de Neuroendocrinologie Expérimentale, Institut National de la Santé et de la Recherche Médicale U501, UFR de Médecine secteur Nord, boulevard Pierre Dramard, 13916, Marseille cedex 20, France. E-mail: . grino.m{at}jean-roche.univ-mrs.fr

Abstract

Glucocorticoids play an important role in determining adipose tissue metabolism and distribution. Patients with Cushing’s syndrome or receiving corticosteroid therapy develop a reversible visceral obesity. In obese patients, although circulating concentrations of cortisol are not consistently elevated, local conversion of inactive cortisone to active cortisol in adipose tissue, catalyzed by 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD-1), could amplify glucocorticoid signaling. We have studied, using semiquantitative in situ hybridization, 11ß-HSD-1 mRNA expression in the adipocyte and stromal compartments of sc abdominal adipose tissue obtained from 12 lean patients and sc abdominal and visceral adipose tissue obtained from 18 obese patients. 11ß-HSD-1 mRNA was expressed in adipocytes, stroma, and walls of vessels. Localization of 11ß-HSD-1 mRNA did not differ between lean sc and obese sc or visceral adipose tissue. 11ß-HSD-1 mRNA levels were significantly (P = 0.0106) increased in the adipocyte compartment of sc adipose tissue obtained from obese patients as compared with nonobese ones, whereas no significant change (P = 0.446) was found in the stromal compartment. In obese patients, 11ß-HSD-1 mRNA expression was increased (P = 0.0157) in the stromal compartment of visceral compared with sc tissue, whereas no significant change (P = 0.8767) was found in the adipocyte compartment.

In summary, our data show that 11ß-HSD-1 mRNA is increased in adipose tissue from obese patients, in the abdominal sc fat in adipocytes and in the visceral fat in both adipocytes and stroma. This observation suggests that an overexpression of 11ß-HSD-1 may explain part of the glucocorticoid-induced metabolic disorders linked to obesity and may promote visceral fat deposition.




This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
S. Sai, C. L. Esteves, V. Kelly, Z. Michailidou, K. Anderson, A. P. Coll, Y. Nakagawa, T. Ohzeki, J. R. Seckl, and K. E. Chapman
Glucocorticoid Regulation of the Promoter of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Is Indirect and Requires CCAAT/Enhancer-Binding Protein-{beta}
Mol. Endocrinol., September 1, 2008; 22(9): 2049 - 2060.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Balachandran, H. Guan, M. Sellan, S. van Uum, and K. Yang
Insulin and Dexamethasone Dynamically Regulate Adipocyte 11{beta}-Hydroxysteroid Dehydrogenase Type 1
Endocrinology, August 1, 2008; 149(8): 4069 - 4079.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
K. Yang, H. Guan, E. Arany, D. J. Hill, and X. Cao
Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor
FASEB J, July 1, 2008; 22(7): 2452 - 2464.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
I J Bujalska, L L Gathercole, J W Tomlinson, C Darimont, J Ermolieff, A N Fanjul, P A Rejto, and P M Stewart
A novel selective 11{beta}-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis
J. Endocrinol., May 1, 2008; 197(2): 297 - 307.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. A. De Sousa Peixoto, S. Turban, J. H. Battle, K. E. Chapman, J. R. Seckl, and N. M. Morton
Preadipocyte 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Is a Keto-Reductase and Contributes to Diet-Induced Visceral Obesity in Vivo
Endocrinology, April 1, 2008; 149(4): 1861 - 1868.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Boullu-Ciocca, V. Achard, V. Tassistro, A. Dutour, and M. Grino
Postnatal Programming of Glucocorticoid Metabolism in Rats Modulates High-Fat Diet-Induced Regulation of Visceral Adipose Tissue Glucocorticoid Exposure and Sensitivity and Adiponectin and Proinflammatory Adipokines Gene Expression in Adulthood
Diabetes, March 1, 2008; 57(3): 669 - 677.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
B. R Walker
Glucocorticoids and Cardiovascular Disease
Eur. J. Endocrinol., November 1, 2007; 157(5): 545 - 559.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Arai, H. Masuzaki, T. Tanaka, T. Ishii, S. Yasue, N. Kobayashi, T. Tomita, M. Noguchi, T. Kusakabe, J. Fujikura, et al.
Ceramide and Adenosine 5'-Monophosphate-Activated Protein Kinase Are Two Novel Regulators of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity in Cultured Preadipocytes
Endocrinology, November 1, 2007; 148(11): 5268 - 5277.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Silaghi, V. Achard, O. Paulmyer-Lacroix, T. Scridon, V. Tassistro, I. Duncea, K. Clement, A. Dutour, and M. Grino
Expression of adrenomedullin in human epicardial adipose tissue: role of coronary status
Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1443 - E1450.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. Barat, D. E. W. Livingstone, C. M. C. Elferink, C. R. McDonnell, B. R. Walker, and R. Andrew
Effects of Gonadectomy on Glucocorticoid Metabolism in Obese Zucker Rats
Endocrinology, October 1, 2007; 148(10): 4836 - 4843.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F. Dadoun, P. Darmon, V. Achard, S. Boullu-Ciocca, F. Philip-Joet, M. C. Alessi, M. Rey, M. Grino, and A. Dutour
Effect of sleep apnea syndrome on the circadian profile of cortisol in obese men
Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E466 - E474.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
Z. Michailidou, A. P Coll, C. J Kenyon, N. M Morton, S. O'Rahilly, J. R Seckl, and K. E Chapman
Peripheral mechanisms contributing to the glucocorticoid hypersensitivity in proopiomelanocortin null mice treated with corticosterone
J. Endocrinol., July 1, 2007; 194(1): 161 - 170.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
M. Qatanani and M. A. Lazar
Mechanisms of obesity-associated insulin resistance: many choices on the menu
Genes & Dev., June 15, 2007; 21(12): 1443 - 1455.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Berthiaume, M. Laplante, W. Festuccia, Y. Gelinas, S. Poulin, J. Lalonde, D. R. Joanisse, R. Thieringer, and Y. Deshaies
Depot-Specific Modulation of Rat Intraabdominal Adipose Tissue Lipid Metabolism by Pharmacological Inhibition of 11{beta}-Hydroxysteroid Dehydrogenase Type 1
Endocrinology, May 1, 2007; 148(5): 2391 - 2397.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Kim, K. A. Temple, S. A. Jones, K. N. Meredith, J. L. Basko, and M. J. Brady
Differential Modulation of 3T3-L1 Adipogenesis Mediated by 11beta-Hydroxysteroid Dehydrogenase-1 Levels
J. Biol. Chem., April 13, 2007; 282(15): 11038 - 11046.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. J. Wake, N. Z. M. Homer, R. Andrew, and B. R. Walker
Acute In Vivo Regulation of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Activity by Insulin and Intralipid Infusions in Humans
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4682 - 4688.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Basu, D. S. Edgerton, R. J. Singh, A. Cherrington, and R. A. Rizza
Splanchnic Cortisol Production in Dogs Occurs Primarily in the Liver: Evidence for Substantial Hepatic Specific 11{beta} Hydroxysteroid Dehydrogenase Type 1 Activity
Diabetes, November 1, 2006; 55(11): 3013 - 3019.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
P. Darmon, F. Dadoun, S. Boullu-Ciocca, M. Grino, M.-C. Alessi, and A. Dutour
Insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity
Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E995 - E1002.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
B. Mariniello, V. Ronconi, S. Rilli, P. Bernante, M. Boscaro, F. Mantero, and G. Giacchetti
Adipose tissue 11{beta}-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome
Eur. J. Endocrinol., September 1, 2006; 155(3): 435 - 441.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
V. S. Densmore, N. M. Morton, J. J. Mullins, and J. R. Seckl
11{beta}-Hydroxysteroid Dehydrogenase Type 1 Induction in the Arcuate Nucleus by High-Fat Feeding: A Novel Constraint to Hyperphagia?
Endocrinology, September 1, 2006; 147(9): 4486 - 4495.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Basu, R. Singh, A. Basu, C.M. Johnson, and R. A. Rizza
Effect of Nutrient Ingestion on Total-Body and Splanchnic Cortisol Production in Humans
Diabetes, March 1, 2006; 55(3): 667 - 674.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. M. Morton, V. Densmore, M. Wamil, L. Ramage, K. Nichol, L. Bunger, J. R. Seckl, and C. J. Kenyon
A Polygenic Model of the Metabolic Syndrome With Reduced Circulating and Intra-Adipose Glucocorticoid Action
Diabetes, December 1, 2005; 54(12): 3371 - 3378.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Grino
Prenatal nutritional programming of central obesity and the metabolic syndrome: role of adipose tissue glucocorticoid metabolism
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1233 - R1235.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. G. Gnanalingham, A. Mostyn, M. E. Symonds, and T. Stephenson
Ontogeny and nutritional programming of adiposity in sheep: potential role of glucocorticoid action and uncoupling protein-2
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1407 - R1415.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. M. Paterson, J. R. Seckl, and J. J. Mullins
Genetic manipulation of 11{beta}-hydroxysteroid dehydrogenases in mice
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R642 - R652.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
A. Hermanowski-Vosatka, J. M. Balkovec, K. Cheng, H. Y. Chen, M. Hernandez, G. C. Koo, C. B. Le Grand, Z. Li, J. M. Metzger, S. S. Mundt, et al.
11{beta}-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice
J. Exp. Med., August 15, 2005; 202(4): 517 - 527.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
S. Arampatzis, B. Kadereit, D. Schuster, Z. Balazs, R. A S Schweizer, F. J Frey, T. Langer, and A. Odermatt
Comparative enzymology of 11{beta}-hydroxysteroid dehydrogenase type 1 from six species
J. Mol. Endocrinol., August 1, 2005; 35(1): 89 - 101.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
N. Draper and P. M Stewart
11{beta}-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action
J. Endocrinol., August 1, 2005; 186(2): 251 - 271.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Basu, R. J. Singh, A. Basu, E. G. Chittilapilly, M. C. Johnson, G. Toffolo, C. Cobelli, and R. A. Rizza
Obesity and Type 2 Diabetes Do Not Alter Splanchnic Cortisol Production in Humans
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3919 - 3926.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Andrew, J. Westerbacka, J. Wahren, H. Yki-Jarvinen, and B. R. Walker
The Contribution of Visceral Adipose Tissue to Splanchnic Cortisol Production in Healthy Humans
Diabetes, May 1, 2005; 54(5): 1364 - 1370.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. Apostolova, R. A. S. Schweizer, Z. Balazs, R. M. Kostadinova, and A. Odermatt
Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue
Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E957 - E964.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. E. Kershaw, N. M. Morton, H. Dhillon, L. Ramage, J. R. Seckl, and J. S. Flier
Adipocyte-Specific Glucocorticoid Inactivation Protects Against Diet-Induced Obesity
Diabetes, April 1, 2005; 54(4): 1023 - 1031.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. C. Sandeep, R. Andrew, N. Z.M. Homer, R. C. Andrews, K. Smith, and B. R. Walker
Increased In Vivo Regeneration of Cortisol in Adipose Tissue in Human Obesity and Effects of the 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Carbenoxolone
Diabetes, March 1, 2005; 54(3): 872 - 879.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. J. Drake, D. E. W. Livingstone, R. Andrew, J. R. Seckl, N. M. Morton, and B. R. Walker
Reduced Adipose Glucocorticoid Reactivation and Increased Hepatic Glucocorticoid Clearance as an Early Adaptation to High-Fat Feeding in Wistar Rats
Endocrinology, February 1, 2005; 146(2): 913 - 919.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Boullu-Ciocca, A. Dutour, V. Guillaume, V. Achard, C. Oliver, and M. Grino
Postnatal Diet-Induced Obesity in Rats Upregulates Systemic and Adipose Tissue Glucocorticoid Metabolism During Development and in Adulthood: Its Relationship With the Metabolic Syndrome
Diabetes, January 1, 2005; 54(1): 197 - 203.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. W. Tomlinson, E. A. Walker, I. J. Bujalska, N. Draper, G. G. Lavery, M. S. Cooper, M. Hewison, and P. M. Stewart
11{beta}-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response
Endocr. Rev., October 1, 2004; 25(5): 831 - 866.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Kannisto, K. H. Pietilainen, E. Ehrenborg, A. Rissanen, J. Kaprio, A. Hamsten, and H. Yki-Jarvinen
Overexpression of 11{beta}-Hydroxysteroid Dehydrogenase-1 in Adipose Tissue Is Associated with Acquired Obesity and Features of Insulin Resistance: Studies in Young Adult Monozygotic Twins
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4414 - 4421.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Valsamakis, A. Anwar, J. W. Tomlinson, C. H. L. Shackleton, P. G. McTernan, R. Chetty, P. J. Wood, A. K. Banerjee, G. Holder, A. H. Barnett, et al.
11{beta}-Hydroxysteroid Dehydrogenase Type 1 Activity in Lean and Obese Males with Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4755 - 4761.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Basu, R. J. Singh, A. Basu, E. G. Chittilapilly, C. M. Johnson, G. Toffolo, C. Cobelli, and R. A. Rizza
Splanchnic Cortisol Production Occurs in Humans: Evidence for Conversion of Cortisone to Cortisol Via the 11-{beta} Hydroxysteroid Dehydrogenase (11{beta}-HSD) Type 1 Pathway
Diabetes, August 1, 2004; 53(8): 2051 - 2059.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. M. Sharma
Mediastinal Fat, Insulin Resistance, and Hypertension
Hypertension, August 1, 2004; 44(2): 117 - 118.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. W. Tomlinson, J. S. Moore, P. M. S. Clark, G. Holder, L. Shakespeare, and P. M. Stewart
Weight Loss Increases 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression in Human Adipose Tissue
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2711 - 2716.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. M. Morton, L. Ramage, and J. R. Seckl
Down-Regulation of Adipose 11{beta}-Hydroxysteroid Dehydrogenase Type 1 by High-Fat Feeding in Mice: A Potential Adaptive Mechanism Counteracting Metabolic Disease
Endocrinology, June 1, 2004; 145(6): 2707 - 2712.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. M. Paterson, N. M. Morton, C. Fievet, C. J. Kenyon, M. C. Holmes, B. Staels, J. R. Seckl, and J. J. Mullins
Metabolic syndrome without obesity: Hepatic overexpression of 11{beta}-hydroxysteroid dehydrogenase type 1 in transgenic mice
PNAS, May 4, 2004; 101(18): 7088 - 7093.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. A. S. Schweizer, M. Zurcher, Z. Balazs, B. Dick, and A. Odermatt
Rapid Hepatic Metabolism of 7-Ketocholesterol by 11{beta}-Hydroxysteroid Dehydrogenase Type 1: SPECIES-SPECIFIC DIFFERENCES BETWEEN THE RAT, HUMAN, AND HAMSTER ENZYME
J. Biol. Chem., April 30, 2004; 279(18): 18415 - 18424.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. M. Morton, J. M. Paterson, H. Masuzaki, M. C. Holmes, B. Staels, C. Fievet, B. R. Walker, J. S. Flier, J. J. Mullins, and J. R. Seckl
Novel Adipose Tissue-Mediated Resistance to Diet-Induced Visceral Obesity in 11{beta}-Hydroxysteroid Dehydrogenase Type 1-Deficient Mice
Diabetes, April 1, 2004; 53(4): 931 - 938.
[Abstract] [Full Text] [PDF]

Home page
 Recent Prog Horm ResHome page
J. R. Seckl, N. M. Morton, K. E. Chapman, and B. R. Walker
Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Recent Prog. Horm. Res., January 1, 2004; 59(1): 359 - 393.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Westerbacka, H. Yki-Jarvinen, S. Vehkavaara, A.-M. Hakkinen, R. Andrew, D. J. Wake, J. R. Seckl, and B. R. Walker
Body Fat Distribution and Cortisol Metabolism in Healthy Men: Enhanced 5{beta}-Reductase and Lower Cortisol/Cortisone Metabolite Ratios in Men with Fatty Liver
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4924 - 4931.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. J. Wake, E. Rask, D. E. W. Livingstone, S. Soderberg, T. Olsson, and B. R. Walker
Local and Systemic Impact of Transcriptional Up-Regulation of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue in Human Obesity
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3983 - 3988.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Mattsson, M. Lai, J. Noble, E. McKinney, J. L. Yau, J. R. Seckl, and B. R. Walker
Obese Zucker Rats Have Reduced Mineralocorticoid Receptor and 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression in Hippocampus--Implications for Dysregulation of the Hypothalamic-Pituitary-Adrenal Axis in Obesity
Endocrinology, July 1, 2003; 144(7): 2997 - 3003.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. S. Lindsay, D. J. Wake, S. Nair, J. Bunt, D. E. W. Livingstone, P. A. Permana, P. A. Tataranni, and B. R. Walker
Subcutaneous Adipose 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Activity and Messenger Ribonucleic Acid Levels Are Associated with Adiposity and Insulinemia in Pima Indians and Caucasians
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2738 - 2744.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B. R. Walker and R. Andrew
Cortisol Metabolism in Type 2 Diabetes
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2951 - 2952.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. W. Tomlinson, N. Crabtree, P. M. S. Clark, G. Holder, A. A. Toogood, C. H. L. Shackleton, and P. M. Stewart
Low-Dose Growth Hormone Inhibits 11{beta}-Hydroxysteroid Dehydrogenase Type 1 but Has No Effect upon Fat Mass in Patients with Simple Obesity
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2113 - 2118.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. C. Andrews, O. Rooyackers, and B. R. Walker
Effects of the 11{beta}-Hydroxysteroid Dehydrogenase Inhibitor Carbenoxolone on Insulin Sensitivity in Men with Type 2 Diabetes
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 285 - 291.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. C. Andrews, O. Herlihy, D. E. W. Livingstone, R. Andrew, and B. R. Walker
Abnormal Cortisol Metabolism and Tissue Sensitivity to Cortisol in Patients with Glucose Intolerance
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5587 - 5593.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society